Green: Stable for now
Your answers suggest continuity risk is currently manageable. Keep a 90-day view and maintain monthly review habits.
What this tool reviews
- Insurance status
- Prior authorization status
- Current estimated monthly medication cost
- Confidence in refill reliability
- Do you know your next renewal deadline?
- Do you have a contingency reserve for delays or changes?
- Has a source or pathway change already been suggested?
- Are you already experiencing refill friction?
Result buckets
Yellow: Friction building
Your answers suggest the next 30-60 days may get unstable without earlier planning. Tighten paperwork, deadlines, and refill follow-up now.
Red: High continuity risk
Your answers suggest the main risk is not just price. It is a combination of cost pressure, refill uncertainty, and poor fallback planning. Move the review forward before a gap forces a rushed decision.
Read next
Frequently Asked Questions
Why think in 90-day windows instead of month to month?
A 90-day view is more realistic because it captures initiation, stabilization, renewal timing, and the refill friction that often gets missed in a month-one budget.
What is the biggest hidden cost driver?
Continuity failure is often the biggest hidden cost driver. Delays, poor paperwork, and rushed switching can create more burden than the sticker price alone suggests.
When should I compare branded and compounded options?
Compare pathways during planning, not in the middle of a refill crisis. That gives you more room to verify documentation and continuity expectations before changing course.
Does this replace payer or pharmacy advice?
No. It is a planning aid that helps organize questions for your clinician, payer, and pharmacy before a continuity problem becomes urgent.
Start the next step
This tool is educational only. It does not replace clinician guidance, payer instructions, pharmacy coordination, or emergency care.